KATIE WEATHERLY: Open Payments
NPI 1861167884 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,244 in 94 payments from 11 companies in 2025. Trend: 2023 $1,824 · 2024 $2,264 · 2025 $2,244
Food & beverage: $2,244
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 49 | $1,148 |
| Janssen Biotech, Inc. | 5 | $295 |
| Amgen Inc. | 14 | $226 |
| AstraZeneca Pharmaceuticals LP | 8 | $162 |
| Novartis Pharmaceuticals Corporation | 6 | $122 |
| UCB, Inc. | 1 | $79 |
| GlaxoSmithKline, LLC. | 3 | $66 |
| E.R. Squibb & Sons, L.L.C. | 2 | $45 |
| GENZYME CORPORATION | 2 | $36 |
| Lilly USA, LLC | 2 | $35 |
Products named: RINVOQ, TREMFYA, SKYRIZI, SAPHNELO, COSENTYX, OTEZLA, TAVNEOS, Bimzelx.
Industry payments across OH — which companies pay providers there.
